| Literature DB >> 29212028 |
Joseph L Regan1, Dirk Schumacher2, Stephanie Staudte3, Andreas Steffen4, Johannes Haybaeck5, Ulrich Keilholz6, Caroline Schweiger7, Nicole Golob-Schwarzl7, Dominik Mumberg4, David Henderson4, Hans Lehrach8, Christian R A Regenbrecht9, Reinhold Schäfer10, Martin Lange11.
Abstract
Colon cancer is a heterogeneous tumor driven by a subpopulation of cancer stem cells (CSCs). To study CSCs in colon cancer, we used limiting dilution spheroid and serial xenotransplantation assays to functionally define the frequency of CSCs in a panel of patient-derived cancer organoids. These studies demonstrated cancer organoids to be enriched for CSCs, which varied in frequency between tumors. Whole-transcriptome analysis identified WNT and Hedgehog signaling components to be enhanced in CSC-enriched tumors and in aldehyde dehydrogenase (ALDH)-positive CSCs. Canonical GLI-dependent Hedgehog signaling is a negative regulator of WNT signaling in normal intestine and intestinal tumors. Here, we show that Hedgehog signaling in colon CSCs is autocrine SHH-dependent, non-canonical PTCH1 dependent, and GLI independent. In addition, using small-molecule inhibitors and RNAi against SHH-palmitoylating Hedgehog acyltransferase (HHAT), we demonstrate that non-canonical Hedgehog signaling is a positive regulator of WNT signaling and required for colon CSC survival.Entities:
Keywords: HHAT; PTCH1; SHH; WNT pathway; cancer organoid; cancer stem cell; colon cancer; non-canonical Hedgehog signaling
Mesh:
Substances:
Year: 2017 PMID: 29212028 DOI: 10.1016/j.celrep.2017.11.025
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423